Unbound MEDLINE

Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets. Mini reviews in medicinal chemistry [Mini Rev Med Chem] Journal article

 
Braumann C, Tangermann J, Jacobi CA, Müller JM, Dubiel W 
Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets. [Journal Article, Review]
Mini Rev Med Chem 2008 May; 8(5):421-8.


Preclinical studies revealed that curcumin, the yellow curry pigment, emodin, a compound derived from grapes, and taurolidine, derived from a biogenic amino acid, and some of their structural homologs possess anti-angiogenic and cancer chemopreventive properties. Whereas curcumin and emodin can act via inhibition of COP9 signalosome-associated kinases, taurolidine blocks protein biosynthesis.



More from this journalRelated subjects (MeSH)
  
Advertise on this site.